The main results of the trial, published last year in The New England Journal of Medicine , showed a 20% reduction in the risk of MACE in 8,803 participants who took semaglutide, compared with 8,801 participants who took an identical-looking placebo
There is one exception: if Wegovy is prescribed for a covered indication other than weight loss (the drug has a separate FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease and BMI 27), some Medicare plans may cover it under that indication
Understanding Potassium-Rich Foods Many foods naturally contain potassium, especially fruits, vegetables, and certain proteins
2.6% with semaglutide 2.4 mg and placebo, respectively) at 104 weeks 24
The Ideal Timeline: When Are You Ready for Surgery